Bray June Insider Trades

Insider Trading History

Track insider trading activity for Bray June. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $19.7k 17,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.2k 17,000 shares
$2.01
$1.16
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $19.3k 18,724 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.2k 18,724 shares
$3.00
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $27.8k 27,000 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.4k 27,000 shares
$1.09
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $31.2k 30,282 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.9k 30,282 shares
$1.88
$1.03
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $19.7k 17,000 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$392k 17,000 shares
$23.04
$1.16
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $27.8k 27,000 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.1k 27,000 shares
$0.82
$1.03
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $19.7k 17,000 shares
Last Trade
Jun 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.77M 17,000 shares
$280.32
$1.16
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $27.8k 27,000 shares
Last Trade
May 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.7k 27,000 shares
$1.58
$1.03
Cortexyme
Cortexyme CRTX
Director
Holding Value $105k 54,000 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$173k 54,000 shares
$3.20
$1.95
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $19.7k 17,000 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.6M 17,000 shares
$211.84
$1.16
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $29k 25,000 shares
Last Trade
Jun 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.1M 25,000 shares
$605.76
$1.16
BioXcel Therapeutics
BioXcel Therapeutics BTAI
Director
Holding Value $4.83k 4,167 shares
Last Trade
Mar 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.71M 4,167 shares
$891.36
$1.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up